TISSO Naturprodukte GmbH pracuje s nejmodernj vrobn technologi
Theres a perception that if a drug isn't approved, that just means its not approved yet
when-is-glutathione-injection-medically-justified There are clinical scenarios where glutathione injections may be beneficialespecially in patients with: Chronic liver disease (e.g., hepatitis, fatty liver) Neurodegenerative disorders (e.g., Parkinsons disease) Certain cancers undergoing chemotherapy, where antioxidant support may help reduce toxicity However, these treatments are closely monitored and personalized to each patients needs
doi:10.1007/s10522-025-10315-x Khavinson VK, Pendina AA, Efimova OA, et al
Key Highlights: Strong timing: Core patent expired in India last month Novos oral patent (Rybelsus) valid till 2031, but DRL has secured approval to move ahead Already approved in Canada + filings in multiple emerging markets GLP-1 portfolio now covers both injectables and orals a strategic advantage While Q4 numbers were impacted by one-offs (revenue -12%, PAT -86%), the company is clearly doubling down on complex generics and high-value opportunities in the GLP-1 space